Roberto Corti

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. ncbi request reprint Long-term patient benefit with biodegradable polymer biolimus eluting stent
    R Corti
    Andreas Grüntzig Laboratories Cardiology, University Hospital Zurich, Zurich, Switzerland
    Minerva Cardioangiol 60:629-36. 2012
  2. ncbi request reprint Noninvasive imaging of atherosclerotic vessels by MRI for clinical assessment of the effectiveness of therapy
    Roberto Corti
    Cardiology, University Hospital Zurich, Ramistrasse 100, CH 8091 Zurich, Switzerland
    Pharmacol Ther 110:57-70. 2006
  3. doi request reprint Cocoa and cardiovascular health
    Roberto Corti
    Cardiovascular Center, Cardiology, University Hospital, Raemistrasse 100, CH 8091 Zurich, Switzerland
    Circulation 119:1433-41. 2009
  4. doi request reprint Imaging of atherosclerosis: magnetic resonance imaging
    Roberto Corti
    Cardiology, Cardiovascular Center, University Hospital Zurich, Ramistrasse 100, CH 8091 Zurich, Switzerland
    Eur Heart J 32:1709-19b. 2011
  5. doi request reprint Reconstituted HDL in acute coronary syndromes
    Remy Chenevard
    Cardiovascular Center, Cardiology, University Hospital, Zurich, Switzerland
    Cardiovasc Ther 30:e51-7. 2012
  6. doi request reprint Cardiovascular effects of flavanol-rich chocolate in patients with heart failure
    Andreas J Flammer
    Cardiovascular Center, Cardiology University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland
    Eur Heart J 33:2172-80. 2012
  7. ncbi request reprint Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial
    Mario Togni
    Department of Cardiology, University Hospital Bern, Switzerland
    J Am Coll Cardiol 50:1123-31. 2007
  8. ncbi request reprint Chronic treatment with long-acting nifedipine reduces vasoconstriction to endothelin-1 in essential hypertension
    Isabella Sudano
    Cardiovascular Center, Cardiology, University Hospital of Zurich, Zurich, Switzerland
    Hypertension 49:285-90. 2007
  9. ncbi request reprint Dark chocolate improves coronary vasomotion and reduces platelet reactivity
    Andreas J Flammer
    Cardiovascular Center, Cardiology, University Hospital Zurich, Raemistr 100, CH 8091 Zurich, Switzerland
    Circulation 116:2376-82. 2007
  10. doi request reprint Acetaminophen increases blood pressure in patients with coronary artery disease
    Isabella Sudano
    Cardiovascular Center Cardiology University Hospital Zurich, Ramistrasse 100, CH 8091 Zurich, Switzerland
    Circulation 122:1789-96. 2010

Detail Information

Publications71

  1. ncbi request reprint Long-term patient benefit with biodegradable polymer biolimus eluting stent
    R Corti
    Andreas Grüntzig Laboratories Cardiology, University Hospital Zurich, Zurich, Switzerland
    Minerva Cardioangiol 60:629-36. 2012
    ..Biodegradable polymer DES are more likely to define the 3rd generation DES. The goal of future development is to further increase safety and efficacy of DES...
  2. ncbi request reprint Noninvasive imaging of atherosclerotic vessels by MRI for clinical assessment of the effectiveness of therapy
    Roberto Corti
    Cardiology, University Hospital Zurich, Ramistrasse 100, CH 8091 Zurich, Switzerland
    Pharmacol Ther 110:57-70. 2006
    ..Thus, MRI opens new strategies ranging from screening of high-risk patients for early detection and treatment as well as monitoring the target areas for pharmacological intervention...
  3. doi request reprint Cocoa and cardiovascular health
    Roberto Corti
    Cardiovascular Center, Cardiology, University Hospital, Raemistrasse 100, CH 8091 Zurich, Switzerland
    Circulation 119:1433-41. 2009
    ..This review summarizes the available data on the cardiovascular effects of cocoa, outlines potential mechanisms involved in the response to cocoa, and highlights the potential clinical implications associated with its consumption...
  4. doi request reprint Imaging of atherosclerosis: magnetic resonance imaging
    Roberto Corti
    Cardiology, Cardiovascular Center, University Hospital Zurich, Ramistrasse 100, CH 8091 Zurich, Switzerland
    Eur Heart J 32:1709-19b. 2011
    ..Such strategy is currently under clinical investigation...
  5. doi request reprint Reconstituted HDL in acute coronary syndromes
    Remy Chenevard
    Cardiovascular Center, Cardiology, University Hospital, Zurich, Switzerland
    Cardiovasc Ther 30:e51-7. 2012
    ....
  6. doi request reprint Cardiovascular effects of flavanol-rich chocolate in patients with heart failure
    Andreas J Flammer
    Cardiovascular Center, Cardiology University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland
    Eur Heart J 33:2172-80. 2012
    ..As statins are ineffective in CHF, alternative therapies are a clinical need. We therefore investigated whether FRC might improve cardiovascular function in patients with CHF...
  7. ncbi request reprint Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial
    Mario Togni
    Department of Cardiology, University Hospital Bern, Switzerland
    J Am Coll Cardiol 50:1123-31. 2007
    ....
  8. ncbi request reprint Chronic treatment with long-acting nifedipine reduces vasoconstriction to endothelin-1 in essential hypertension
    Isabella Sudano
    Cardiovascular Center, Cardiology, University Hospital of Zurich, Zurich, Switzerland
    Hypertension 49:285-90. 2007
    ..Those vasculoprotective effects may importantly contribute to a reduction in major clinical events seen during treatment with these compounds...
  9. ncbi request reprint Dark chocolate improves coronary vasomotion and reduces platelet reactivity
    Andreas J Flammer
    Cardiovascular Center, Cardiology, University Hospital Zurich, Raemistr 100, CH 8091 Zurich, Switzerland
    Circulation 116:2376-82. 2007
    ..Thus, flavonoid-rich dark chocolate holds the potential to have a beneficial impact on graft atherosclerosis...
  10. doi request reprint Acetaminophen increases blood pressure in patients with coronary artery disease
    Isabella Sudano
    Cardiovascular Center Cardiology University Hospital Zurich, Ramistrasse 100, CH 8091 Zurich, Switzerland
    Circulation 122:1789-96. 2010
    ..Hence, the aim of this study was to evaluate the safety of acetaminophen in patients with coronary artery disease...
  11. doi request reprint Cholesterylestertransfer protein inhibition and endothelial function in type II hyperlipidemia
    Frank Hermann
    University Hospital Zurich, Zurich, Switzerland
    Thromb Res 123:460-5. 2009
    ....
  12. ncbi request reprint Protection of endothelial function: targets for nutritional and pharmacological interventions
    Isabella Sudano
    Cardiovascular Center, Cardiology, University Hospital and Cardiovascular Research, Institute of Physiology, University Zurich Irchel, Zurich, Switzerland
    J Cardiovasc Pharmacol 47:S136-50; discussion S172-6. 2006
    ..This review discusses pharmacological and dietary intervention...
  13. ncbi request reprint Assessment of inflammatory response to transfemoral transcatheter aortic valve implantation compared to transapical and surgical procedures: a pilot study
    Barbara E Stähli
    Department of Cardiology, Cardiovascular Center, University Hospital Zurich, Ramistrasse 100, 8091 Zurich, Switzerland
    J Invasive Cardiol 24:407-11. 2012
    ..Surgical aortic valve replacement (AVR) has been associated with systemic inflammatory reactions. Yet, the role of inflammation following transcatheter aortic valve implantation (TAVI) has not been fully elucidated...
  14. doi request reprint Cocoa, blood pressure, and vascular function
    Isabella Sudano
    Cardiovascular Center Cardiology, University Hospital Zurich, Raemistrasse 100, CH 8091, Zurich, Switzerland
    Curr Hypertens Rep 14:279-84. 2012
    ..It is the aim of this review to summarize the findings of cocoa and chocolate on blood pressure and vascular function...
  15. ncbi request reprint Coffee blunts mental stress-induced blood pressure increase in habitual but not in nonhabitual coffee drinkers
    Isabella Sudano
    Cardiovascular Center, Cardiology, University Hospital Zurich, Zurich, Switzerland
    Hypertension 46:521-6. 2005
    ..Caffeine alone does not exert any potentiating effect, confirming that ingredients other than caffeine are partially responsible for the stimulating effect of coffee on the cardiovascular system...
  16. doi request reprint Myeloid related proteins activate Toll-like receptor 4 in human acute coronary syndromes
    Keiko Yonekawa
    Department of Cardiology, Cardiovascular Center, University Hospital Zurich, Switzerland
    Atherosclerosis 218:486-92. 2011
    ..In human ACS, we investigated now whether the pro-inflammatory action of MRPs occurs through TLR4 in monocytes derived from thrombi...
  17. ncbi request reprint Cardiovascular effects of coffee: is it a risk factor?
    Isabella Sudano
    Department of Internal Medicine, Cardiology Unit, University Hospital Zurich, Zurich, Switzerland
    Prog Cardiovasc Nurs 20:65-9. 2005
    ..In contrast to early studies, recent research indicates that habitual moderate coffee intake does not represent a health hazard and may even be associated with beneficial effects on cardiovascular health...
  18. doi request reprint Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis
    Andreas J Flammer
    Cardiovascular Centre, Cardiology, University Hospital, Ramistrasse 100, 8091 Zurich, Switzerland
    Circulation 117:2262-9. 2008
    ....
  19. doi request reprint Spontanous periodic breathing is associated with sympathetic hyperreactivity and baroreceptor dysfunction in hypertension
    Christian Binggeli
    Cardiovascular Center Cardiology, University Hospital Zurich, Switzerland
    J Hypertens 28:985-92. 2010
    ..Treating apnea improves hypertension and reduces sympathetic outflow. The aim of the present study was to investigate the phenomenon and mechanisms of spontaneous periodic breathing in patients with hypertension...
  20. doi request reprint Predictors for efficacy of percutaneous mitral valve repair using the MitraClip system: the results of the MitraSwiss registry
    Daniel Sürder
    Department of Cardiology, University Hospital Zurich, Zurich, Switzerland
    Heart 99:1034-40. 2013
    ..Percutaneous mitral valve repair (MVR) using the MitraClip system has become a valid alternative for patients with severe mitral regurgitation (MR) and high operative risk...
  21. doi request reprint Real-time left ventricular pressure-volume loops during percutaneous mitral valve repair with the MitraClip system
    Oliver Gaemperli
    Andreas Grüntzig Cardiac Catheterization Laboratories, University Hospital Zurich, Zurich, Switzerland
    Circulation 127:1018-27. 2013
    ..However, its effects on left ventricular loading conditions and contractility have not been investigated yet...
  22. doi request reprint Pharmacologic preconditioning therapy prior to atrial septal defect closure in patients at high risk for acute pulmonary edema
    Christiane Gruner
    Division of Cardiology, University Hospital, Zurich, Switzerland
    J Interv Cardiol 25:505-12. 2012
    ..The aim of this study was to assess whether transient atrial septal defect (ASD) occlusion and, if required, vasodilator therapy would improve the safety of percutaneous ASD closure in high-risk subsets...
  23. ncbi request reprint Dysfunctional baroreflex regulation of sympathetic nerve activity in patients with vasovagal syncope
    Markus Bechir
    Cardiovascular Center, Cardiology, University Hospital, Ramistrasse 100, 8091 Zurich, Switzerland
    Circulation 107:1620-5. 2003
    ..Hence, the aim of the present study was to investigate MSA, baroreceptor sensitivity, heart rate, and blood pressure under resting conditions and during orthostatic stress in patients with a history of vasovagal syncope...
  24. ncbi request reprint Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromes
    Lukas A Altwegg
    Cardiovascular Center, Cardiology, University Hospital Zurich, Ramistrasse 100, CH 8091 Zurich, Switzerland
    Eur Heart J 28:941-8. 2007
    ..We investigated whether myeloid-related protein 8/14 complex (MRP8/14) expressed by infiltrating monocytes and granulocytes may represent a mediator and early biomarker of acute coronary syndromes (ACS)...
  25. ncbi request reprint Statins enhance postischemic hyperemia in the skin circulation of hypercholesterolemic patients: a monitoring test of endothelial dysfunction for clinical practice?
    Christian Binggeli
    Cardiovascular Center, Division of Cardiology, University Hospital, CH 8091 Zurich, Switzerland
    J Am Coll Cardiol 42:71-7. 2003
    ..The present study aims to investigate whether laser Doppler flowmetry can be used to monitor improvements in vascular function during statin therapy...
  26. doi request reprint Integrated x-ray and echocardiography imaging for structural heart interventions
    Roberto Corti
    HeartClinic Hirslanden, Klinik Hirslanden, Zurich, Switzerland
    EuroIntervention 9:863-9. 2013
    ..This new imaging technology seeks to improve the communication between the echocardiographer and the interventionalist, to increase the confidence and anatomical awareness, to assist in guidance, and to increase procedural efficiency. ..
  27. doi request reprint Acute haemodynamic changes after percutaneous mitral valve repair: relation to mid-term outcomes
    Oliver Gaemperli
    Andreas Gruntzig Laboratories, Cardiovascular Center, University Hospital Zurich, Ramistrasse 100, Zurich, Switzerland
    Heart 98:126-32. 2012
    ..Percutaneous mitral valve repair (MVR) using the Evalve MitraClip has been recently introduced as a potential alternative to surgical MVR...
  28. doi request reprint Feasibility of the Engager™ aortic transcatheter valve system using a flexible over-the-wire design
    Simon H Sündermann
    Division of Cardiac and Vascular Surgery, University Hospital Zurich, Zurich, Switzerland
    Eur J Cardiothorac Surg 42:e48-52. 2012
    ..The aim was to investigate the safety and feasibility of the redesigned Engager™ transcatheter aortic valve implantation (TAVI) system...
  29. doi request reprint Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function
    Daniel Sürder
    Department of Cardiology, Cardiovascular Center, University Hospital Zurich, 8091 Zurich, Switzerland
    Circulation 127:1968-79. 2013
    ..The optimal time point of administration of BM-MNC is still uncertain and has rarely been addressed prospectively in randomized clinical trials...
  30. ncbi request reprint Coffee acutely increases sympathetic nerve activity and blood pressure independently of caffeine content: role of habitual versus nonhabitual drinking
    Roberto Corti
    Cardiovascular Center, Cardiology, University Hospital Zurich, Switzerland
    Circulation 106:2935-40. 2002
    ..Activation of the sympathetic nervous system by coffee may enhance cardiovascular risk; however, it is unclear whether this effect of coffee is related to caffeine or other substance(s) also contained in decaffeinated coffee...
  31. doi request reprint Outcome of patients treated with engager transapical aortic valve implantation: one-year results of the feasibility study
    Simon H Sündermann
    From the Division of Cardiovascular Surgery, and Division of Cardiology, University Hospital Zurich, Zurich, Switzerland Department of Cardiac Surgery, and Department of Cardiology, Heart Center Leipzig, Leipzig, Germany and Department of Cardiovascular Surgery, German Heart Centre Munich, Munich, Germany
    Innovations (Phila) 8:332-6. 2013
    ..The aim of this study was to investigate the short-term and midterm outcome of the Engager transcatheter aortic valve implantation (TAVI) system, a transapical self-expanding valve device with anatomic orientation...
  32. ncbi request reprint Mental stress induces prolonged endothelial dysfunction via endothelin-A receptors
    Lukas E Spieker
    Cardiology, University Hospital, Zurich, Switzerland
    Circulation 105:2817-20. 2002
    ..6+/-1.2 versus 9.4+/-1.3%; NS). In contrast, intraarterial infusion of norepinephrine of similar duration as mental stress did not inhibit FMD...
  33. ncbi request reprint [Dark or white chocolate? Cocoa and cardiovascular health]
    Roberto Corti
    Cardiovascular Center, Cardiology, University Hospital, Raemistrasse 100, 8091 Zurich
    Rev Med Suisse 6:499-500, 502-4. 2010
    ..This article reviews available data about the effects of the consumption of cocoa and different types of chocolate on cardiovascular health, and outlines potential mechanisms involved on the basis of recent studies...
  34. doi request reprint Fractional flow reserve evaluation in patients considered for transfemoral transcatheter aortic valve implantation: a case series
    Barbara E Stähli
    Department of Cardiology, Cardiovascular Center, University Hospital Zurich, Zurich, Switzerland
    Cardiology 123:234-9. 2012
    ..Concomitant coronary artery disease (CAD) is frequently encountered in this patient population and may have an impact on outcomes. Hence, in patients with both severe AS and CAD, a bespoke therapy of both AS and/or CAD appears mandatory...
  35. doi request reprint Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial
    Giulio G Stefanini
    Department of Cardiology, University of Bern, Switzerland
    Lancet 378:1940-8. 2011
    ..We report the 4 year follow-up of an assessment of biodegradable polymer-based drug-eluting stents, which aim to improve safety by avoiding the persistent inflammatory stimulus of durable polymers...
  36. doi request reprint Whole-heart dynamic three-dimensional magnetic resonance perfusion imaging for the detection of coronary artery disease defined by fractional flow reserve: determination of volumetric myocardial ischaemic burden and coronary lesion location
    Robert Manka
    Institute for Biomedical Engineering, University and ETH Zurich, Zurich, Switzerland
    Eur Heart J 33:2016-24. 2012
    ....
  37. doi request reprint Cellular actors, Toll-like receptors, and local cytokine profile in acute coronary syndromes
    Christophe A Wyss
    Department of Cardiology, Cardiovascular Center, University Hospital, Ramistrasse 100, CH 8091 Zurich, Switzerland
    Eur Heart J 31:1457-69. 2010
    ..We characterized leucocytes and TLR expression within coronary thrombi and compared cytokine levels from the site of coronary occlusion with aortic blood (AB) in ACS patients...
  38. ncbi request reprint Time course of hemoglobin concentrations in the intensive care unit in nonbleeding patients with acute coronary syndrome
    Marco Previsdomini
    Division of Medical Intensive Care, University Hospital, Zurich, Switzerland
    Am J Cardiol 100:579-82. 2007
    ..We hypothesize that this decrease is due to normalization of the previous stress-induced hemoconcentration and "internal hemodilution" by nitroglycerin...
  39. ncbi request reprint Cardiovascular disease in HIV infection
    Isabella Sudano
    Cardiology, Cardiovascular Center, University Hospital Zurich, Switzerland
    Am Heart J 151:1147-55. 2006
    ..When initiating lipid-lowering therapy, interactions between statins and HIV protease inhibitors affecting cytochrome P450 function must be considered. Restenosis rate after percutaneous coronary intervention may be unexpectedly high...
  40. doi request reprint Assessment of mitral valve area during percutaneous mitral valve repair using the MitraClip system: comparison of different echocardiographic methods
    Patric Biaggi
    Division of Echocardiography, Andreas Grüntzig Cardiac Catheterization Laboratories, Cardiology, Clinic for Cardiovascular Surgery, and Department of Anesthesiology, University Hospital Zurich, Zurich, Switzerland and the Institute for Social and Preventive Medicine, University of Zurich, Zurich, Switzerland
    Circ Cardiovasc Imaging 6:1032-40. 2013
    ..Quantification of the mitral valve area (MVA) is important to guide percutaneous mitral valve repair using the MitraClip system. However, little is known about how to best assess MVA in this specific situation...
  41. ncbi request reprint Failure to retrieve undeployed paclitaxel-eluting coronary stents
    Marco Roffi
    Department of Cardiology, University Hospital Zurich, Zurich, Switzerland
    Am J Cardiol 97:502-5. 2006
    ..The clinical consequences were chronic claudication due to lower extremity device embolization in 1 patient and urgent surgical stent removal in 1 patient...
  42. doi request reprint Early and late mortality in patients undergoing transcatheter aortic valve implantation: comparison of the novel EuroScore II with established risk scores
    Barbara E Stähli
    Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland
    Cardiology 126:15-23. 2013
    ..In the evaluation of patients considered for transcatheter aortic valve implantation (TAVI), the EuroScore II might be superior to established risk scores...
  43. ncbi request reprint Lyme carditis: restitutio ad integrum documented by cardiac magnetic resonance imaging
    Bilgehan Karadag
    Department of Cardiology, University Hospital, Zurich, Switzerland
    Cardiol Rev 12:185-7. 2004
    ..Complete resolution without signs of myocardial scar is demonstrated by cardiac magnetic resonance imaging...
  44. ncbi request reprint Percutaneous closure of patent foramen ovale and valvular function -- effect of the amplatzer occluder
    Nazmi Krasniqi
    Department of Cardiology, Cardiovascular Center, University Hospital Zurich, Switzerland
    J Invasive Cardiol 24:274-7. 2012
    ..Whether or not implantation of a PFO closure device alters cardiac chamber anatomy and in turn affects valvular function is unclear...
  45. pmc Carotid artery stenting: a single center "real world" experience
    Nazmi Krasniqi
    Cardiology, Cardiovascular Center, University Hospital Zurich, Switzerland
    PLoS ONE 7:e35300. 2012
    ..However its role compared to carotid endarterectomy (CAD) remains questioned. We analysed the safety of carotid artery stenting program of a prospective CAS register program of a tertiary teaching hospital...
  46. ncbi request reprint Effects of chronic calcium channel blockade on sympathetic nerve activity in hypertension
    Christian Binggeli
    Cardiovascular Center, Division of Cardiology, University Hospital, Zurich, Switzerland
    Hypertension 39:892-6. 2002
    ..Thus, in hypertension slow release forms of verapamil, nifedipine, and amlodipine exert comparable antihypertensive effects and do not change MSA, although there was a trend toward decreased MSA and plasma norepinephrine with verapamil...
  47. doi request reprint Associated vascular lesions in patients with spontaneous coronary artery dissection
    Stefan Toggweiler
    Cardiovascular Center, Cardiology, University Hospital Zurich, Switzerland
    Swiss Med Wkly 142:w13538. 2012
    ..To identify vascular abnormalities in patients presenting with spontaneous coronary artery dissection (SCAD)...
  48. doi request reprint Acute, subacute, and chronic myocardial infarction: quantitative comparison of 2D and 3D late gadolinium enhancement MR imaging
    Robert Goetti
    Department of Diagnostic Radiology, University Hospital Zurich, Raemistrasse 100, CH 8091 Zurich, Switzerland
    Radiology 259:704-11. 2011
    ....
  49. doi request reprint Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial
    Stephan Windecker
    Department of Cardiology, and CTU Bern, Bern University Hospital, Bern, Switzerland
    Lancet 372:1163-73. 2008
    ..We compared the safety and efficacy of a biolimus-eluting stent (with biodegradable polymer) with a sirolimus-eluting stent (with durable polymer)...
  50. ncbi request reprint Rapid progression of atherosclerotic coronary artery disease in patients with human immunodeficiency virus infection
    Lukas E Spieker
    Department of Cardiology, University Hospital Zurich, Ramistrasse 100, CH 8091, Zurich, Switzerland
    Heart Vessels 20:171-4. 2005
    ..The rate of progression of coronary artery disease and the restenosis rate, however, are often unexpectedly high in these patients...
  51. ncbi request reprint Shear stress-dependent platelet function after LDL cholesterol apheresis
    Lukas E Spieker
    Cardiology, University Hospital, CH 8091 Zurich, Switzerland
    Thromb Res 113:395-8. 2004
    ..The aim of the present study was to investigate the effects lipid lowering by LDL apheresis on platelet function in patients with coronary artery disease...
  52. doi request reprint Cell-based therapy for myocardial repair in patients with acute myocardial infarction: rationale and study design of the SWiss multicenter Intracoronary Stem cells Study in Acute Myocardial Infarction (SWISS-AMI)
    Daniel Sürder
    Department of Cardiology, University Hospital Zurich, Zurich, Switzerland
    Am Heart J 160:58-64. 2010
    ..Furthermore, reliable clinical predictors are lacking for identifying patients who are thought to have most benefit from cellular therapy...
  53. ncbi request reprint Cardiac arrest in a soccer player: a unique case of anomalous coronary origin detected by 16-row multislice computed tomography coronary angiography
    Bilgehan Karadag
    Department of Cardiology, University Hospital Zurich, Ramistrasse 100, CH 8091, Zurich, Switzerland
    Heart Vessels 20:116-9. 2005
    ..Multislice contrast-enhanced computed tomography has emerged as a valid noninvasive method for the diagnosis of coronary artery anomaly...
  54. ncbi request reprint High-density lipoprotein restores endothelial function in hypercholesterolemic men
    Lukas E Spieker
    Cardiology, University Hospital, Zurich, Switzerland
    Circulation 105:1399-402. 2002
    ..Therefore, we investigated the effects of reconstituted HDL on endothelial function in hypercholesterolemic men...
  55. ncbi request reprint Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization
    Stephan Windecker
    Department of Cardiology, University Hospital Bern, Bern, Switzerland
    N Engl J Med 353:653-62. 2005
    ..Sirolimus-eluting stents and paclitaxel-eluting stents, as compared with bare-metal stents, reduce the risk of restenosis. It is unclear whether there are differences in safety and efficacy between the two types of drug-eluting stents...
  56. pmc Coronary optical frequency domain imaging (OFDI) for in vivo evaluation of stent healing: comparison with light and electron microscopy
    Christian Templin
    Department of Cardiology, Cardiovascular Center, University Hospital Zurich, Raemistrasse 100, 8091 Zurich, Switzerland
    Eur Heart J 31:1792-801. 2010
    ..Hence, the present study was designed to evaluate the capacity of coronary OFDI by electron (SEM) and light microscopy (LM) analysis to detect and evaluate stent strut coverage in a porcine model...
  57. ncbi request reprint Transcatheter aortic valve implantation (TAVI) outcome according to standardized endpoint definitions by the Valve Academic Research Consortium (VARC)
    Barbara E Stähli
    Department of Cardiology, Cardiovascular Center, University Hospital Zurich, Rämistress 100, 8091 Zurich, Switzerland
    J Invasive Cardiol 23:307-12. 2011
    ..Transcatheter aortic valve implantation (TAVI) has become an accepted treatment option for severe aortic stenosis (AS) in high-risk individuals. Yet, current results are difficult to compare given the lack of standardized definitions...
  58. doi request reprint Shunt reduction with a fenestrated Amplatzer device
    Oliver Kretschmar
    Division of Pediatric Cardiology, University Children s Hospital, Zurich, Switzerland
    Catheter Cardiovasc Interv 76:564-71. 2010
    ..We report our experiences with an interventional approach for shunt-reduction using various modifications of a self-fabricated Amplatzer device in our institution...
  59. pmc Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease
    Christian Besler
    Cardiology, Cardiovascular Center, University Hospital Zurich, Zurich, Switzerland
    J Clin Invest 121:2693-708. 2011
    ....
  60. ncbi request reprint Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein
    Willibald Maier
    Division of Cardiology, University Hospital Zurich, Ramistrasse 100, CH 8091 Zurich, Switzerland
    Circulation 111:1355-61. 2005
    ..Acute myocardial infarction (AMI) is associated with inflammation. However, it remains unclear whether it originates from the ruptured plaque or represents a systemic process...
  61. ncbi request reprint C-reactive protein influences shear stress-dependent platelet adhesion in patients with familiar hypercholesterolemia and coronary artery disease undergoing LDL apheresis
    Lukas E Spieker
    Thromb Haemost 96:540-2. 2006
  62. ncbi request reprint In vivo noninvasive detection and age definition of arterial thrombus by MRI
    Roberto Corti
    Cardiovascular Biology Research Laboratory, Mount Sinai Medical Center, New York, New York, USA
    J Am Coll Cardiol 39:1366-73. 2002
    ..BACKGROUND; Arterial thrombi underlie the clinical consequences of atherosclerosis and are not reliably detected by current noninvasive diagnostic techniques...
  63. ncbi request reprint Fenofibrate induces plaque regression in hypercholesterolemic atherosclerotic rabbits: in vivo demonstration by high-resolution MRI
    Roberto Corti
    Cardiovascular Biology Research Laboratory, Cardiovascular Institute, Mount Sinai Medical School of Medicine, One Gustave Levy Place, P O Box 1030, New York, NY 10029, USA
    Atherosclerosis 190:106-13. 2007
    ..We investigated the anti-atherogenic effects of fenofibrate on previously established experimental atherosclerotic lesions...
  64. ncbi request reprint Does shear stress modulate both plaque progression and regression in the thoracic aorta? Human study using serial magnetic resonance imaging
    Jolanda J Wentzel
    Cardiovascular Institute, Mount Sinai School of Medicine, New York, New York, USA
    J Am Coll Cardiol 45:846-54. 2005
    ..The purpose of this study was to investigate the role of shear stress (SS) in plaque regression...
  65. ncbi request reprint Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging
    Roberto Corti
    Cardiovascular Biology Research Laboratory, Mount Sinai School of Medicine, New York, NY 10029, USA
    Circulation 106:2884-7. 2002
    ..Noninvasive MRI allows serial monitoring of atherosclerotic plaque size changes. Our aim was to investigate the effects of lipid lowering with simvastatin on atherosclerotic lesions...
  66. ncbi request reprint Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging
    Roberto Corti
    Cardiovascular Biology Research Laboratory, Mount Sinai School of Medicine, New York, New York 10029, USA
    J Am Coll Cardiol 46:106-12. 2005
    ..This study sought to compare the effects of aggressive and conventional lipid lowering by two different dosages of the same statin on early human atherosclerotic lesions using serial noninvasive magnetic resonance imaging (MRI)...
  67. ncbi request reprint Biologic aspects of vulnerable plaque
    Roberto Corti
    Cardiovascular Biology Research Laboratory and the Zena and Michael A Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY 10029, USA
    Curr Opin Cardiol 17:616-25. 2002
    ....
  68. ncbi request reprint The vulnerable plaque and acute coronary syndromes
    Roberto Corti
    Cardiovascular Biology Research Laboratory, Mount Sinai School of Medicine, New York, New York, USA
    Am J Med 113:668-80. 2002
    ..These regimens focus on inhibiting thrombin, preventing thrombi generation, blocking the initiation of coagulation, inhibiting platelet activation, and increasing fibrinolysis...
  69. ncbi request reprint Aspirin and clopidogrel in acute coronary syndromes: therapeutic insights from the CURE study
    Hani Jneid
    Division of Cardiology, University of Louisville, Louisville, KY, USA
    Arch Intern Med 163:1145-53. 2003
    ..Aspirin resistance can be assessed through platelet aggregometry testing, measurement of urinary thromboxane metabolites, and, possibly, genomic testing in the future...
  70. ncbi request reprint Emerging importance of HDL cholesterol in developing high-risk coronary plaques in acute coronary syndromes
    Juan F Viles-Gonzalez
    Cardiovascular Biology Research Laboratory, Zena and Michael A Weiner Cardiovascular Institute, Mount Sinai School of Medicine, New York, New York 10029, USA
    Curr Opin Cardiol 18:286-94. 2003
    ....
  71. ncbi request reprint Should standard medical therapy for angina include a statin?
    Roberto Corti
    Zena and Michael A Wiener Cardiovascular Institute, The Mount Sinai School of Medicine, New York, New York 10029, USA
    Clin Cardiol 27:547-51. 2004
    ..This article reviews the most recent evidence and guideline recommendations supporting the use of statins in chronic stable angina pectoris and acute coronary syndromes...